Detection of yellow fever virus: a comparison of quantitative real-time PCR and plaque assay

被引:96
作者
Bae, HG
Nitsche, A
Teichmann, A
Biel, SS
Niedrig, M
机构
[1] Robert Koch Inst, D-13353 Berlin, Germany
[2] Humboldt Univ, Charite, Med Klin MS Onkol & Hamatol 2, Berlin, Germany
关键词
yellow fever virus; 17D; plaque assay; real-time PCR; TaqMan;
D O I
10.1016/S0166-0934(03)00129-0
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Yellow fever virus quantitation is performed routinely by cultivation of virus containing samples using susceptible cells. Counting of the resulting plaques provides a marker for the number of infectious particles present in the sample. This assay usually takes up to 5 days before results are obtained and must be carried out under L2 or U laboratory conditions, depending on the yellow fever virus strain used. For clinical diagnosis of yellow fever virus infections the cell culture-based approach takes too long and is of limited practical relevance. Recently, due to its considerable sensitivity, PCR has become a promising method for virus detection. However, whilst PCR can detect virus-specific nucleic acids, it does not allow conclusions to be drawn regarding the infectious potential of the virus detected. Nonetheless, for diagnostic purposes, a rapid, specific and sensitive virus PCR is preferable. Therefore, two independent yellow fever virus-specific real-time PCR assays were established and compared the viral RNA loads to the results of a traditional plaque assay. The estimated ratio of yellow fever virus genomes to infectious particles was between 1000: 1 and 5000: 1; both approaches displayed a comparable precision of < 45%. A significant correlation between genome number as determined by real-time PCR and the corresponding number of plaques in paired samples was found with a Pearson coefficient of correlation of r = 0.88 (P < 0.0001). (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:185 / 191
页数:7
相关论文
共 31 条
  • [1] PREDICTING DNA DUPLEX STABILITY FROM THE BASE SEQUENCE
    BRESLAUER, KJ
    FRANK, R
    BLOCKER, H
    MARKY, LA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (11) : 3746 - 3750
  • [2] ANTIGENIC RELATIONSHIPS BETWEEN FLAVIVIRUSES AS DETERMINED BY CROSS-NEUTRALIZATION TESTS WITH POLYCLONAL ANTISERA
    CALISHER, CH
    KARABATSOS, N
    DALRYMPLE, JM
    SHOPE, RE
    PORTERFIELD, JS
    WESTAWAY, EG
    BRANDT, WE
    [J]. JOURNAL OF GENERAL VIROLOGY, 1989, 70 : 37 - 43
  • [3] FLAVIVIRUS GENOME ORGANIZATION, EXPRESSION, AND REPLICATION
    CHAMBERS, TJ
    HAHN, CS
    GALLER, R
    RICE, CM
    [J]. ANNUAL REVIEW OF MICROBIOLOGY, 1990, 44 : 649 - 688
  • [4] A Belgian traveler who acquired yellow fever in the Gambia
    Colebunders, R
    Mariage, JL
    Coche, JC
    Pirenne, B
    Kempinaire, S
    Hantson, P
    Van Gompel, A
    Niedrig, M
    Van Esbroeck, M
    Bailey, R
    Drosten, C
    Schmitz, H
    [J]. CLINICAL INFECTIOUS DISEASES, 2002, 35 (10) : E113 - E116
  • [5] Reproducibility of detection of tyrosinase and MART-1 transcripts in the peripheral blood of melanoma patients: a quality control study using real-time quantitative RT-PCR
    de Vries, TJ
    Fourkour, A
    Punt, CJA
    van de Locht, LTF
    Wobbes, T
    van den Bosch, S
    de Rooij, MJM
    Mensink, EJBM
    Ruiter, DJ
    van Muijen, GNP
    [J]. BRITISH JOURNAL OF CANCER, 1999, 80 (5-6) : 883 - 891
  • [6] HUMAN FATAL YELLOW-FEVER - IMMUNOHISTOCHEMICAL DETECTION OF VIRAL-ANTIGENS IN THE LIVER, KIDNEY AND HEART
    DEBRITO, T
    SIQUEIRA, SAC
    SANTOS, RTM
    NASSAR, ES
    COIMBRA, TLM
    ALVES, VAF
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 1992, 188 (1-2) : 177 - 181
  • [7] DEMADRID AT, 1969, B WORLD HEALTH ORGAN, V40, P113
  • [8] Deubel V, 1997, J MED VIROL, V53, P212, DOI 10.1002/(SICI)1096-9071(199711)53:3&lt
  • [9] 212::AID-JMV5&gt
  • [10] 3.0.CO